top of page

Biopharma Daily Updates - 12/15/20

Dec 15, 20201 min read

$XBI $146.32 (+0.2%)

 

Data Updates:

$ATNX (-6%) - FDA approval of Klisyri (Tirbanibulin)


$KNSA (+0.5%) - Start enrollment in ph2b of Vixarelimab


$NKTR (+4.5%) - Dosing underway in ph1/2 of NKTR-255 + Cetuximab


$GILD (-0.5%) + $GLPG (-1%) - Agreement for Jyseleca (Filgotinib)


$RDUS (+5%) - Tymlos sales update


Financial Updates

$PHAT (+13%) - Public offering

$TGTX (+17%) - Prices offering at $43.50/share

$MIRM (-23%) - Prices offering at $20/share



0 comments

Comments

bottom of page